IBDEI14W ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18942,2)
 ;;=^5002287
 ;;^UTILITY(U,$J,358.3,18943,0)
 ;;=D77.^^94^916^55
 ;;^UTILITY(U,$J,358.3,18943,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18943,1,3,0)
 ;;=3^Disorder of Blood/Blood-Forming Organs in Diseases Classified Elsewhere,Other
 ;;^UTILITY(U,$J,358.3,18943,1,4,0)
 ;;=4^D77.
 ;;^UTILITY(U,$J,358.3,18943,2)
 ;;=^5002396
 ;;^UTILITY(U,$J,358.3,18944,0)
 ;;=D58.2^^94^916^81
 ;;^UTILITY(U,$J,358.3,18944,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18944,1,3,0)
 ;;=3^Hemoglobinopathies,Other
 ;;^UTILITY(U,$J,358.3,18944,1,4,0)
 ;;=4^D58.2
 ;;^UTILITY(U,$J,358.3,18944,2)
 ;;=^87629
 ;;^UTILITY(U,$J,358.3,18945,0)
 ;;=C88.8^^94^916^101
 ;;^UTILITY(U,$J,358.3,18945,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18945,1,3,0)
 ;;=3^Malig Immunoproliferative Diseases,Other
 ;;^UTILITY(U,$J,358.3,18945,1,4,0)
 ;;=4^C88.8
 ;;^UTILITY(U,$J,358.3,18945,2)
 ;;=^5001750
 ;;^UTILITY(U,$J,358.3,18946,0)
 ;;=D70.8^^94^916^170
 ;;^UTILITY(U,$J,358.3,18946,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18946,1,3,0)
 ;;=3^Neutropenia,Other
 ;;^UTILITY(U,$J,358.3,18946,1,4,0)
 ;;=4^D70.8
 ;;^UTILITY(U,$J,358.3,18946,2)
 ;;=^334042
 ;;^UTILITY(U,$J,358.3,18947,0)
 ;;=D59.4^^94^916^171
 ;;^UTILITY(U,$J,358.3,18947,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18947,1,3,0)
 ;;=3^Nonautoimmune Hemolytic Anemias,Other
 ;;^UTILITY(U,$J,358.3,18947,1,4,0)
 ;;=4^D59.4
 ;;^UTILITY(U,$J,358.3,18947,2)
 ;;=^5002326
 ;;^UTILITY(U,$J,358.3,18948,0)
 ;;=D69.59^^94^916^177
 ;;^UTILITY(U,$J,358.3,18948,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18948,1,3,0)
 ;;=3^Secondary Thrombocytopenia,Other
 ;;^UTILITY(U,$J,358.3,18948,1,4,0)
 ;;=4^D69.59
 ;;^UTILITY(U,$J,358.3,18948,2)
 ;;=^5002369
 ;;^UTILITY(U,$J,358.3,18949,0)
 ;;=C22.7^^94^916^44
 ;;^UTILITY(U,$J,358.3,18949,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18949,1,3,0)
 ;;=3^Carcinomas of Liver,Other Spec
 ;;^UTILITY(U,$J,358.3,18949,1,4,0)
 ;;=4^C22.7
 ;;^UTILITY(U,$J,358.3,18949,2)
 ;;=^5000938
 ;;^UTILITY(U,$J,358.3,18950,0)
 ;;=D75.89^^94^916^54
 ;;^UTILITY(U,$J,358.3,18950,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18950,1,3,0)
 ;;=3^Diseases of Blood/Blood-Forming Organs,Other Spec
 ;;^UTILITY(U,$J,358.3,18950,1,4,0)
 ;;=4^D75.89
 ;;^UTILITY(U,$J,358.3,18950,2)
 ;;=^5002392
 ;;^UTILITY(U,$J,358.3,18951,0)
 ;;=D47.Z9^^94^916^169
 ;;^UTILITY(U,$J,358.3,18951,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18951,1,3,0)
 ;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior,Other
 ;;^UTILITY(U,$J,358.3,18951,1,4,0)
 ;;=4^D47.Z9
 ;;^UTILITY(U,$J,358.3,18951,2)
 ;;=^5002262
 ;;^UTILITY(U,$J,358.3,18952,0)
 ;;=D05.82^^94^916^32
 ;;^UTILITY(U,$J,358.3,18952,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18952,1,3,0)
 ;;=3^Carcinoma in Situ Left Breast,Other Spec Type
 ;;^UTILITY(U,$J,358.3,18952,1,4,0)
 ;;=4^D05.82
 ;;^UTILITY(U,$J,358.3,18952,2)
 ;;=^5001934
 ;;^UTILITY(U,$J,358.3,18953,0)
 ;;=D05.81^^94^916^34
 ;;^UTILITY(U,$J,358.3,18953,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18953,1,3,0)
 ;;=3^Carcinoma in Situ Right Breast,Oth Spec Type
 ;;^UTILITY(U,$J,358.3,18953,1,4,0)
 ;;=4^D05.81
 ;;^UTILITY(U,$J,358.3,18953,2)
 ;;=^5001933
 ;;^UTILITY(U,$J,358.3,18954,0)
 ;;=D05.80^^94^916^36
 ;;^UTILITY(U,$J,358.3,18954,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18954,1,3,0)
 ;;=3^Carcinoma in Situ Unspec Breast,Oth Spec Type
 ;;^UTILITY(U,$J,358.3,18954,1,4,0)
 ;;=4^D05.80
 ;;^UTILITY(U,$J,358.3,18954,2)
 ;;=^5001932
 ;;^UTILITY(U,$J,358.3,18955,0)
 ;;=D56.8^^94^916^182
 ;;^UTILITY(U,$J,358.3,18955,1,0)
 ;;=^358.31IA^4^2
